Literature DB >> 17076262

Methods and platforms for the quantification of splice variants' expression.

Laurent Bracco1, Emeline Throo, Olivier Cochet, Richard Einstein, Florence Maurier.   

Abstract

The relatively limited number of human protein encoding genes highlights the importance of the diversity generated at the level of the mRNA transcripts. As alternative RNA splicing plays a key role in mediating this diversity, it becomes critical to develop the tools and platforms that will deliver quantitative information on the specific expression levels associated with splice isoforms. This chapter describes the constraints generated by this global transcriptome analysis and the state-of-the-art techniques and products available to the scientific community.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076262     DOI: 10.1007/978-3-540-34449-0_1

Source DB:  PubMed          Journal:  Prog Mol Subcell Biol        ISSN: 0079-6484


  5 in total

1.  High-throughput quantification of splicing isoforms.

Authors:  Jean-Philippe Brosseau; Jean-François Lucier; Elvy Lapointe; Mathieu Durand; Daniel Gendron; Julien Gervais-Bird; Karine Tremblay; Jean-Pierre Perreault; Sherif Abou Elela
Journal:  RNA       Date:  2009-12-28       Impact factor: 4.942

Review 2.  Analysis of protein isoforms: can we do it better?

Authors:  Miroslava Stastna; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2012-09-19       Impact factor: 3.984

Review 3.  Genomics, transcriptional profiling, and heart failure.

Authors:  Kenneth B Margulies; Daniel P Bednarik; Daniel L Dries
Journal:  J Am Coll Cardiol       Date:  2009-05-12       Impact factor: 24.094

4.  Myocardial alternative RNA splicing and gene expression profiling in early stage hypoplastic left heart syndrome.

Authors:  Marco Ricci; Yanji Xu; Harriet L Hammond; David A Willoughby; Lubov Nathanson; Maria M Rodriguez; Matteo Vatta; Steven E Lipshultz; Joy Lincoln
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

5.  Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.

Authors:  Paul E R Ellery; Susan A Maroney; Nicholas D Martinez; Marvin P Wickens; Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.